For people with Alpha-1, finding the right diagnosis and treatment plan go hand in hand. And with ZEMAIRA, you get a therapy that can deliver the experience you deserve.
Dosing and administration that may help simplify the treatment process
No refrigeration required
Infuse in as little as 15 minutes*
* Average infusion time is based on an infusion rate of 0.08 mL/kg/min for a 165lb patient. Individual experiences may vary.
ZEMAIRA has been used for more than 16 years with no confirmed cases of virus transmission
Made in state-of-the-art facilities
ZEMAIRA is purified from human plasma and undergoes a rigorous virus removal and inactivation process
While all efforts are made to prevent transmission of infectious agents and viruses, the risk of transmission cannot be completely eliminated.
ZEMAIRA was proven in clinical trials to raise and maintain levels of the Alpha-1 protein
When administered once a week for 24 weeks at a dose of 60 mg/kg of body weight, patients with Alpha-1 saw a rapid increase in A1AT levels that were maintained throughout the study period*
* Clinical data demonstrating the long-term effects of chronic augmentation therapy with ZEMAIRA are not available.
Studies have shown that A1AT augmentation therapy is safe.
In clinical studies of ZEMAIRA, at least 5% of subjects reported adverse reactions related to treatment, including: